Literature DB >> 33959916

Amyloid β (Aβ) ELISA of Human iPSC-Derived Neuronal Cultures.

Hirotaka Watanabe1, Rei Murakami2, Hideyuki Okano3.   

Abstract

Amyloid β (Aβ) peptides are the main component of the characteristic insoluble deposits in brain parenchyma and small blood vessels in the patients afflicted with Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). These small peptides are attributed to the pathogenesis of both AD and CAA, suggesting an important index for disease stage and progression. In the brain tissue, Aβs are released mainly from neuronal cells into extracellular space. Here, we describe a step-by-step protocol to measure Aβs secreted from human pluripotent stem cell-derived neuronal cells.
© 2021. Springer Science+Business Media, LLC.

Entities:  

Keywords:  Amyloid β (Aβ); Enzyme-Linked Immuno Sorbent Assay (ELISA); Neuronal differentiation; induced pluripotent stem cell (iPSC); β-Secretase; γ-Secretase

Mesh:

Substances:

Year:  2022        PMID: 33959916     DOI: 10.1007/7651_2021_407

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

Authors:  R Vassar; B D Bennett; S Babu-Khan; S Kahn; E A Mendiaz; P Denis; D B Teplow; S Ross; P Amarante; R Loeloff; Y Luo; S Fisher; J Fuller; S Edenson; J Lile; M A Jarosinski; A L Biere; E Curran; T Burgess; J C Louis; F Collins; J Treanor; G Rogers; M Citron
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

2.  A combinational treatment of carotenoids decreases Aβ secretion in human neurons via β-secretase inhibition.

Authors:  Misato Sho; Naoki Ichiyanagi; Kent Imaizumi; Mitsuru Ishikawa; Satoru Morimoto; Hirotaka Watanabe; Hideyuki Okano
Journal:  Neurosci Res       Date:  2019-10-10       Impact factor: 3.304

3.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.

Authors:  B De Strooper; P Saftig; K Craessaerts; H Vanderstichele; G Guhde; W Annaert; K Von Figura; F Van Leuven
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

4.  A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity.

Authors:  Elizabeth A Heilig; Weiming Xia; Jie Shen; Raymond J Kelleher
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

5.  Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Authors:  Takuya Yagi; Daisuke Ito; Yohei Okada; Wado Akamatsu; Yoshihiro Nihei; Takahito Yoshizaki; Shinya Yamanaka; Hideyuki Okano; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-09-07       Impact factor: 6.150

6.  Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice.

Authors:  Hirotaka Watanabe; Dan Xia; Takahisa Kanekiyo; Raymond J Kelleher; Jie Shen
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 7.  Modeling human neurological disorders with induced pluripotent stem cells.

Authors:  Yoichi Imaizumi; Hideyuki Okano
Journal:  J Neurochem       Date:  2013-12-15       Impact factor: 5.372

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 9.  Modeling Alzheimer's disease with iPSC-derived brain cells.

Authors:  Jay Penney; William T Ralvenius; Li-Huei Tsai
Journal:  Mol Psychiatry       Date:  2019-08-07       Impact factor: 15.992

10.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.